• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Sensitivity of Trichomonas vaginalis to metronidazole, tinidazole, and nifuratel in vitro.阴道毛滴虫对甲硝唑、替硝唑和硝呋太尔的体外敏感性。
Br J Vener Dis. 1976 Dec;52(6):404-8. doi: 10.1136/sti.52.6.404.
2
Effect of 5-Nitroimidazole Drugs against Trichomonas vaginalis Clinical Isolates.5-硝基咪唑类药物对阴道毛滴虫临床分离株的作用。
Microbiol Spectr. 2022 Aug 31;10(4):e0091222. doi: 10.1128/spectrum.00912-22. Epub 2022 Jul 13.
3
Strain of Trichomonas vaginalis resistant to metronidazole and other 5-nitroimidazoles.对甲硝唑和其他5-硝基咪唑类药物耐药的阴道毛滴虫菌株。
Antimicrob Agents Chemother. 1979 Feb;15(2):254-7. doi: 10.1128/AAC.15.2.254.
4
Metronidazole-resistant Trichomonas vaginalis.甲硝唑耐药阴道毛滴虫
Br J Vener Dis. 1979 Oct;55(5):351-3. doi: 10.1136/sti.55.5.351.
5
In vitro effect of tinidazole and furazolidone on metronidazole-resistant Trichomonas vaginalis.替硝唑和呋喃唑酮对甲硝唑耐药阴道毛滴虫的体外作用
Antimicrob Agents Chemother. 1996 May;40(5):1121-5. doi: 10.1128/AAC.40.5.1121.
6
In vitro metronidazole and tinidazole activities against metronidazole-resistant strains of Trichomonas vaginalis.体外甲硝唑和替硝唑对甲硝唑耐药阴道毛滴虫菌株的活性。
Antimicrob Agents Chemother. 2003 Apr;47(4):1407-9. doi: 10.1128/AAC.47.4.1407-1409.2003.
7
Prevalence of Trichomonas vaginalis isolates with resistance to metronidazole and tinidazole.对甲硝唑和替硝唑耐药的阴道毛滴虫分离株的流行率。
Antimicrob Agents Chemother. 2006 Dec;50(12):4209-10. doi: 10.1128/AAC.00814-06. Epub 2006 Sep 25.
8
Prevalence of 5-nitroimidazole-resistant trichomonas vaginalis in Oviedo, Spain.西班牙奥维耶多地区对5-硝基咪唑耐药的阴道毛滴虫的流行情况。
Sex Transm Dis. 2001 Feb;28(2):115-6. doi: 10.1097/00007435-200102000-00010.
9
A metronidazole-resistant strain of Trichomonas vaginalis and its sensitivity to Go 10213.一株甲硝唑耐药性阴道毛滴虫及其对Go 10213的敏感性
J Antimicrob Chemother. 1984 Oct;14(4):423-6. doi: 10.1093/jac/14.4.423.
10
Study of the Susceptibility of Clinical Isolates of Trichomonas vaginalis to Metronidazole and Secnidazole.阴道毛滴虫临床分离株对甲硝唑和塞克硝唑敏感性的研究。
Antimicrob Agents Chemother. 2018 Mar 27;62(4). doi: 10.1128/AAC.02329-17. Print 2018 Apr.

引用本文的文献

1
Improvement of vaginal health for Kenyan women at risk for acquisition of human immunodeficiency virus type 1: results of a randomized trial.改善肯尼亚有感染1型人类免疫缺陷病毒风险的女性的阴道健康:一项随机试验的结果。
J Infect Dis. 2008 May 15;197(10):1361-8. doi: 10.1086/587490.
2
Metronidazole. A therapeutic review and update.甲硝唑:治疗综述与更新
Drugs. 1997 Nov;54(5):679-708. doi: 10.2165/00003495-199754050-00003.
3
Metronidazole resistance of Trichomonas vaginalis as a cause of treatment failure in trichomoniasis--A case report.滴虫性阴道炎治疗失败原因之一:阴道毛滴虫对甲硝唑耐药——病例报告
Br J Vener Dis. 1982 Dec;58(6):394-9. doi: 10.1136/sti.58.6.394.
4
Use of a time-kill technique for susceptibility testing of Trichomonas vaginalis.使用时间杀菌技术进行阴道毛滴虫药敏试验。
Antimicrob Agents Chemother. 1985 Mar;27(3):332-6. doi: 10.1128/AAC.27.3.332.
5
Persistent Trichomonas vaginalis infection due to a metronidazole-resistant strain.由耐甲硝唑菌株引起的持续性阴道毛滴虫感染。
CMAJ. 1986 Jun 15;134(12):1373-4.
6
Inhibition of Tritrichomonas foetus by vermiculine in vitro.蛭菌素在体外对胎儿三毛滴虫的抑制作用。
Folia Microbiol (Praha). 1978;23(5):389-93. doi: 10.1007/BF02876441.
7
How suitable are available pharmaceuticals for the treatment of sexually transmitted diseases? 1: Conditions presenting as genital discharges.现有药物对性传播疾病的治疗适用性如何?1:表现为生殖器分泌物的病症。
Br J Vener Dis. 1977 Oct;53(5):314-23. doi: 10.1136/sti.53.5.314.
8
Metronidazole-resistant Trichomonas vaginalis.甲硝唑耐药阴道毛滴虫
Br J Vener Dis. 1979 Oct;55(5):351-3. doi: 10.1136/sti.55.5.351.
9
Strain of Trichomonas vaginalis resistant to metronidazole and other 5-nitroimidazoles.对甲硝唑和其他5-硝基咪唑类药物耐药的阴道毛滴虫菌株。
Antimicrob Agents Chemother. 1979 Feb;15(2):254-7. doi: 10.1128/AAC.15.2.254.
10
Secnidazole. A 5-nitroimidazole derivative with a long half-life.塞克硝唑。一种半衰期较长的5-硝基咪唑衍生物。
Br J Vener Dis. 1978 Apr;54(2):77-80. doi: 10.1136/sti.54.2.77.

本文引用的文献

1
Absorption and excretion of metronidazole. I. Serum concentration and urinary excretion after oral administration.甲硝唑的吸收与排泄。I. 口服给药后的血清浓度及尿排泄情况。
Br J Vener Dis. 1961 Dec;37(4):273-5. doi: 10.1136/sti.37.4.273.
2
[BIOLOGICAL PROPERTIES OF N-(5-NITRO-2-FURFURYLIDENE)-3-AMINO-5-METHYLMERCAPTOMETHYL-2-OXAZOLIDINONE].N-(5-硝基-2-糠叉基)-3-氨基-5-甲硫基甲基-2-恶唑烷酮的生物学特性
Farmaco Sci. 1964 Apr;19:301-11.
3
Metronidazole treatment of trichomoniasis in the female. Report of an extended trial.甲硝唑治疗女性滴虫病。一项扩大试验的报告。
Br Med J. 1962 Feb 3;1(5274):276-9. doi: 10.1136/bmj.1.5274.276.
4
Strain sensitivity of Trichomonas vaginalis to metronidazole.阴道毛滴虫对甲硝唑的菌株敏感性。
Br J Vener Dis. 1962 Dec;38(4):218-9. doi: 10.1136/sti.38.4.218.
5
Laboratory studies with the systemic trichomonacide, metronidazole.使用全身性滴虫杀灭剂甲硝唑的实验室研究。
J Clin Pathol. 1961 Jul;14(4):431-5. doi: 10.1136/jcp.14.4.431.
6
[The activity of 1-(2-hydroxyethyl)-2-methyl-5-nitroimidazole (R. P. 8823) against experimental Trichomonas vaginalis infections].[1-(2-羟乙基)-2-甲基-5-硝基咪唑(R.P.8823)对实验性阴道毛滴虫感染的活性]
Ann Inst Pasteur (Paris). 1959 Feb;96(2):238-41.
7
The antitrichomonal activity of amidonitrothiazoles.脒基硝基噻唑类的抗滴虫活性。
J Pharm Pharmacol. 1955 Feb;7(2):112-7. doi: 10.1111/j.2042-7158.1955.tb12014.x.
8
[Observations and problems in the treatment of trichomonas vaginitis].[滴虫性阴道炎治疗中的观察与问题]
Ther Umsch. 1966 Sep;23(9):356-9.
9
[Nitrimidazone, a new systemic trichomonacide].[硝咪唑酮,一种新型全身性抗滴虫药]
G Mal Infett Parassit. 1969 Dec;21(12):954-8.
10
Tinidazole and metronidazole pharmocokinetics in man and mouse.替硝唑和甲硝唑在人和小鼠体内的药代动力学
Antimicrob Agents Chemother (Bethesda). 1969;9:267-70.

阴道毛滴虫对甲硝唑、替硝唑和硝呋太尔的体外敏感性。

Sensitivity of Trichomonas vaginalis to metronidazole, tinidazole, and nifuratel in vitro.

作者信息

Korner B, Jensen H K

出版信息

Br J Vener Dis. 1976 Dec;52(6):404-8. doi: 10.1136/sti.52.6.404.

DOI:10.1136/sti.52.6.404
PMID:1087577
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1045320/
Abstract

Prompted by the sensitivity of trichomonads to metronidazole and nifuratel in clinical practice, a study was conducted in 1971-1972 of 63 consecutive strains of Trichomonas vaginalis isolated from women with clinically refractory vaginal discharge. Their susceptibility to metronidazole, tinidazole, and nifuratel was tested, using a serial tube dilution technique. The minimum concentrations which in 48 hrs caused immobilization and lysis of trichomonads cultured in Diamond's medium was assessed. No differences in drug potency could be determined. The median trichomonistatic and trichomonicidal concentrations were 0-1 and 0-6 mug/ml. respectively when using an inoculum of 10,000 organisms per ml. An inoculum of 100,000 per ml. resulted in inhibitory concentrations of 1-0 and killing concentrations of 3-3 mug./ml. These levels are readily attained in blood and vaginal tissue after oral ingestion of the two imidazole derivatives. Thus, metronidazole has maintained its efficacy since it was first introduced more than a decade ago. The few therapeutic failures with metronidazole and tinidazole are considered to have been caused by pharmacokinetic deficiencies in the patients, or by re-infection.

摘要

鉴于临床实践中滴虫对甲硝唑和硝呋太尔敏感,1971 - 1972年对63株连续从患有临床难治性白带的女性中分离出的阴道毛滴虫菌株进行了一项研究。采用连续试管稀释技术检测了它们对甲硝唑、替硝唑和硝呋太尔的敏感性。评估了在48小时内导致在戴蒙德培养基中培养的滴虫固定和裂解的最低浓度。无法确定药物效力的差异。当每毫升接种10000个生物体时,滴虫生长抑制和杀滴虫的中位数浓度分别为0 - 1微克/毫升和0 - 6微克/毫升。每毫升接种100000个生物体时,抑制浓度为1 - 0微克/毫升,杀灭浓度为3 - 3微克/毫升。口服这两种咪唑衍生物后,血液和阴道组织中很容易达到这些水平。因此,自十多年前首次引入以来,甲硝唑一直保持其疗效。少数甲硝唑和替硝唑治疗失败被认为是由患者的药代动力学缺陷或再次感染引起的。